Home » Newsletters » BioWorld Science

BioWorld Science

July 29, 2014

View Archived Issues

Philips to acquire Unisensor to enhance point-of-care diagnostic business

Celsion reports data from DIGNITY and HEAT studies

OJSC Pharmstandard and Millhouse acquire stakes in Biocad Holding

Otsuka Pharmaceutical signs collaboration agreement with Horizon CombinatoRx

Patient with congestive heart failure treated with combination stem cell treatment

Parnell in-licenses Cimtech compounds for bone and dermal regeneration

GlaxoSmithKline reviews pipeline progress of second quarter 2014

Phase III study of S-1 in hepatocellular carcinoma does not meet primary endpoint

Lpath reports interim data from phase IIa study of Asonep

Decoy Biosystems patents new bacterial agents for cancer

Scientists at Eli Lilly patent novel agents for insomnia

Novel SHIP-1 modulators disclosed by Aquinox Pharmaceuticals

Novel RNA-based transcriptional gene silencing strategy inhibits HIV-1 activation in vitro

Novo Nordisk receives positive CHMP opinion on Xultophy

Envarsus receives European approval for both kidney and liver transplant patients

Kinex Pharmaceuticals confirms FDA allowance of IND application for KX2-391 ointment

Discovery of new HIV-1 Gag mutations linked to protease inhibitor resistance

FDA clears IND for LOR-253 in patients with AML, MDS and other blood cancers

AcelRx Pharmaceuticals receives complete response letter from FDA for Zalviso

Simbrinza approved in the E.U. to treat glaucoma

Retrophin submits proposal to acquire Clinuvel Pharmaceuticals

Researchers in China present new proto-oncogene c-Abl inhibitors for cancer

Imbruvica granted full approval in U.S. for chronic lymphocytic leukemia

Arena Pharmaceuticals designs novel H3 receptor antagonists

Eli Lilly synthesizes novel autotaxin inhibitors for pain

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...